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Abstract
Background
Decisions regarding which vaccines are funded in the United Kingdom (UK) are increasingly
informed by cost-effectiveness analyses. Such analyses use Quality Adjusted Life Years
(QALYs) as a measure of effectiveness and assume that QALYs are equal regardless of
where and in whom they occur in the population. However, there is increasing debate about
whether this QALY approach is appropriate and whether societal preferences for childhood
vaccinations should be used to help inform childhood immunisation policy.
Objective
To gauge the general public’s preferences for prioritising certain characteristics of childhood
vaccination, to help inform future policy making decisions in the UK.
Design
Qualitative design using individual face-to-face interviews, with data analysed using an
inductive thematic framework approach.
Setting
Two counties in England, UK.
Population
Adult members of the general public were recruited using the Bristol and South Gloucester-
shire open electoral registers, using gender and deprivation quotas for each area.
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Participants
21 members of the public participated in qualitative interviews.
Results
The qualitative research identified three major themes and several key attributes that influ-
ences participant’s opinions about priority setting for childhood vaccinations: (1) population
segment (i.e. age group, carer impact and social group), (2) vaccine preventable diseases
preferences (i.e. disease severity, disease incidence and declining infection) and (3) risks
and benefits associated with childhood vaccinations (i.e. vaccine associated side-effects,
herd protection and peace of mind).
Conclusion
Evidence from this qualitative study suggests that some members of the UK general public
have more nuanced views than the health-maximisation approach when considering how
childhood vaccines should be prioritised. This is not necessarily captured by the current eco-
nomic approaches for assessing the benefits from childhood vaccinations in the UK, but is
an important area for future research to ensure appropriate decision making.
Introduction
Cost-effectiveness is a crucial consideration for vaccination programmes in the United King-
dom (UK), as shown by the recent debate and policy decision around the introduction of
Bexsero1 to protect against meningococcal group B disease[1]. Cost-effectiveness analyses
consider the net cost of the intervention against the net health gains that result. The preferred
measure of health gain used by National Institute for Health and Care Excellence (NICE)
and the Joint Committee on Vaccination and Immunisation (JCVI) is the QALY or quality
adjusted life year[2]. The QALY combines both the length of life and the quality of life a person
experiences during that time; one QALY is equal to one year of life in perfect health.
Current economic analyses are conducted on the premise that all QALYs are equal, for
example a QALY gained by a child has the same value as a QALY gained by an adult, or for
any other person in society regardless of demographic factors, background or circumstance
[3]. This methodology assumes that a single person gaining a large improvement in their
health is the same as several people gaining a small improvement in their health[3]. However,
vaccines as a health intervention, particularly in children, are distinctive as they are often given
at a very young age to confer protection into adulthood, thus in this group there may be partic-
ular reasons to reject the conventional wisdom that a “QALY is a QALY is a QALY”. Indeed,
the QALY approach for assessing the benefit from childhood vaccination has been challenged
recently because it does not take into account special consideration of factors and thus could
fail to take into account social preferences[4–7]. For example, people may want to prevent rare
severe diseases more than common mild ones, may fear certain diseases, and may place partic-
ular value on the life-saving preventative nature of vaccination. There have been attempts to
address these issues by defining weights for use in health care[8–12]. These studies, although
not solely focused on the benefits associated with childhood vaccines, have shown that society
has stronger preferences for health gains in younger people, those who are critically ill and the
socioeconomically disadvantaged[8–12]. Other DCE studies and surveys have considered
Prioritising vaccination programmes against childhood diseases
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societal preferences related to health interventions[13–16], nevertheless there remains a pau-
city of evidence within the UK about whether current policy decisions represent public opin-
ion[17], indeed the question of whether the current QALY approach truly reflects UK societal
preferences has not been formally addressed. This study aimed to identify public preferences
for the health gains associated with vaccination and assess whether the current assumption of
equal QALY values is valid when considering childhood vaccination programmes in the UK.
Methods
Study design
An explorative qualitative design using individual, face-to-face interviews with members of the
public. COREQ guidelines have been used in reporting the study conduct and findings.[18]
Setting and participants
We recruited members of the public from two counties in South West England. These counties
were chosen after reviewing the annual (2014–2015) vaccination coverage statistics for chil-
dren aged up to five years in England for Bath and North-East Somerset, Bristol, Gloucester-
shire, North Somerset and South Gloucestershire[19]. Vaccine uptake in children up to the age
of 5 was found to vary the most between Bristol (generally lower) and South Gloucestershire
(generally higher) during this period, therefore these areas were chosen to ensure a population
with some diversity in vaccination uptake would be included in the study. Electronic copies of
the open electoral registers for Bristol City Council and South Gloucestershire City Councils
were obtained and used to identify individuals registered in each district. After data cleaning,
130,791 and 74,862 individuals were listed on the Bristol and South Gloucestershire City
Council electoral register respectively (Fig 1). Postal qualitative interview invitations were sent
to a stratified random sample (based on Indices of Multiple Deprivation decile) of adult indi-
viduals (18 years) recorded on each register.
Potential participants received an English language information sheet describing the pur-
pose and nature of the research and a sheet in ten languages (Arabic, Chinese, Gujarati, Hindi,
Kurdish, Polish, Portuguese, Punjabi, Somali, Urdu) inviting them to take part in the study
and stating that full information in one of the ten languages could be provided. Interested indi-
viduals were asked to return their written informed consent to the University of Bristol study
team if they were willing to participate in the research.
Data collection
Interviews were conducted by the corresponding author G.L. (female/PhD/senior researcher).
G.L. had previously received qualitative interview training and was experienced in conducting
interviews with members of the public. Each participant was interviewed on one occasion and
knew that the research was contributing towards childhood vaccination research. Interviews
were arranged at a time convenient to the participant and conducted in a venue of their choos-
ing (e.g. their home or local coffee shop). No individuals other than G.L. and the participant
were present during the interviews. It was emphasised throughout each interview that partici-
pants could stop the interview or withdraw from the study at any point. A topic guide was
used to ensure participants’ opinions were investigated fully during the interview (see below).
Each interview lasted one hour on average and was audio recorded, with retrospective field
notes created as required. Each interview was transcribed verbatim shortly afterwards; all data
were subsequently anonymised. Each participant received a £10 shopping voucher for their
participation.
Prioritising vaccination programmes against childhood diseases
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Fig 1. Recruitment flow diagram for qualitative interviews.
https://doi.org/10.1371/journal.pone.0197374.g001
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Interview topic guide
A semi-structured interview topic guide was used, this ensured that fixed themes were dis-
cussed during each interview, but also allowed participants to discuss themes that they person-
ally considered to be pertinent. Each interview started with some ‘background mapping’
questions[20] about the participant and their general views about childhood vaccinations,
before moving onto questions about specific health benefits that participants associated with
vaccination (S1 File). The main topic for discussion was the different types of attributes that
policy makers should consider when funding childhood vaccination programmes, including
factors related to disease, the vaccine and who receives the benefit.
Each interview began with two vignettes, which were developed with input from all mem-
bers of the study team (discussed below). These ‘snapshot’ scenarios were used so that two
vaccine preventable disease stories unfolded through a series of stages.[21] This ‘continuous
narrative’ approach [22] was chosen to encourage participants to comment at each stage of
the story and to discuss their own beliefs and opinions about a topic that they potentially
had very little knowledge or experience about. Follow-up questions, probes and qualitative
methods were used to encourage participants to express their views, these methods included,
but were not limited to: flash-cards, think-aloud techniques and open discussion. In later
interviews, as key themes were identified, the topic guide was updated (S2 File) so that the
concluding section of each interview was used to confirm the importance of key themes and
to explore if they should be considered for inclusion in a subsequent DCE questionnaire sur-
vey; this approach allowed suggestions from preceding interviews to be tested with latter
participants.
Analysis
An inductive thematic framework approach[23] was used to analyse batches of between three
and six interview transcripts. Analysis began with thoroughly reading through each transcript
whilst listening to the accompanying audio file; this ensured that all verbal emphases were cap-
tured during the analysis process. After this initial reading of transcripts, a general coding
structure was developed from the data and applied to large sections of text, then paragraphs
and finally to particular sentences. New codes were developed and applied as necessary, with
repeated review of the transcripts to ensure consistency in the application of the coding
scheme. All transcripts were reviewed and compared multiple times until no new codes were
identified[24]. During the coding process the synthesised data were used to generate descrip-
tive accounts in order to identify key attributes and to map the range and diversity of partici-
pants’ opinions[20]. During this analysis process, the preliminary results were discussed by the
whole study team, which assisted in the development of themes and sub-themes. Analysis of
the interview transcripts continued until saturation was achieved, whereby no new themes
were identified.
Data analysis was primarily conducted by G.L. with support from an experienced research
team (H.A.-J., C.L.T., F.E.C. and H.C.) with a range of expertise; (H.A.-J.) health economist
with qualitative research experience and DCE development experience, (F.C.) health psychol-
ogy with qualitative research and DCE development experience, and (C.L.T and H.C.) epide-
miologists. The breadth and range of experience within the research team ensured that
different opinions were discussed during the data interpretation process and the resulting cod-
ing framework was used after being approved by all team members.
Four rounds of interviews were conducted in total, this allowed the study team to meet and
discuss the results before moving on to the next round of interviews. The terminology used by
respondents during the first round of interviews was used to help explain the information
Prioritising vaccination programmes against childhood diseases
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presented to participants in subsequent interviews. The final round of interviews was used to
check for saturation and confirmation of the overall findings.
The whole interview and analysis process was iterative, with the topic guide and key attri-
butes updated using suggestions identified during each round of interviews. Analysis of the
qualitative interview data was managed using NVivo version 10[25], which facilitated organi-
sation of interview transcripts and linkage with participants’ demographic data.
Ethical approval for this study was obtained from the University of Bristol, Faculty of
Health Sciences Research Ethics Committee in Bristol, England (application number 29821).
Results
Interviews took place between March and December 2016. Twenty-three individuals expressed
an interest to participate, with a total of 21 (17 women, 4 men) finally included in this study.
Two potential participants were lost to follow-up after researchers were unable to re-contact
them to arrange an interview after multiple attempts.
Characteristics of participants covered a broad set of ages and parental categories (Table 1;
additional characteristics are provided in the S3 File). Interviews lasted between 33 and 70
minutes with a mean duration of 58 minutes. The thematic qualitative analysis process resulted
in three main themes: social preferences associated with childhood vaccination priority setting,
preferences associated with vaccine preventable diseases, and perception of risks and benefits
associated with childhood vaccinations. Each of these themes includes three categories (Fig 2).
Table 1. Descriptive characteristics of participants (n = 21).
Characteristics Number
Location
South Gloucestershire 9
Bristol 12
Age range of participants (years)
35–44 6
45–54 4
55–64 3
64–74 6
75+ 2
Sex
Female 17
Male 4
Ethnicity
White British 20
White European 1
Parental status
Not a parent/guardian 6
Parent/guardian 13
Parent/guardian and foster carer 2
Highest qualification
A-level or equivalent 2
HNC or equivalent 4
Degree or equivalent 8
Doctorate or equivalent 3
No formal qualifications 4
https://doi.org/10.1371/journal.pone.0197374.t001
Prioritising vaccination programmes against childhood diseases
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Preferences associated with population segments
Preference for different age groups to be vaccinated. Many of the interview participants
were in favour of funding vaccination programmes that targeted specific age groups. This was
because age was considered as a proxy for vulnerability to disease, with the very young ( 1
years) and elderly in society perceived as being more susceptible.
I think 1 year old or less is a vulnerable age group from health wise and you know within
considering possible death, causes of death. Once they get a bit older, say two year olds,
they’re a bit more robust. . .
(Male, parent/guardian, interview #16)
The vulnerability of these two age group extremes seemed to be accentuated within the
youngest age group, with the belief that diseases were more readily contracted and developed
more quickly in younger children.
[S]mall children become unwell very quickly, very quickly indeed. Erm I’m not saying
adults don’t but certainly children, you can see them dramatically go downhill within
hours.
(Female, not a parent/guardian, interview #7)
Further investigation around the age theme showed that some participants made decisions
about rationing vaccinations based on the amount of life remaining, with some making judge-
ments about what constituted a ‘fair-innings’. In these instances, some participants believed
that younger members of society would enjoy the protection from a vaccination for longer
than their older counterparts and consequently vaccination programmes should be funded to
maximise these health benefits.
I’d rather help the young ones to have a longer life that was healthy. . .I think that the young
people that have got a long time left, then there’s more value to it for them. So I’m not say-
ing that you’re not valuable when you’re an older person but. . . it’s a longer time that
they’ve got to live, hopefully, healthily.
(Female, parent/guardian, interview #2)
Preference for ‘carer impact’ to be considered when vaccinating. Some participants
mentioned the effect that vaccine preventable disease had on the quality of life for those
Fig 2. Themes and categories that emerged during analysis. Qualitative themes are presented in the top row and
categories in the bottom row.
https://doi.org/10.1371/journal.pone.0197374.g002
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responsible for caring for a child suffering with vaccine preventable disease. This ‘carer impact’
was thought to be felt most acutely by close family and friends and would affect their emo-
tional health and wellbeing whilst caring for a child during and after their illness.
[J]ust considering the impact on families or, children with diseases that they could’ve been
immunised against. . .it’s a way of making policymakers think about the effects, because
they tend to think in financial terms, not necessarily in effects on the family, on parents, on
siblings and psychological effects. . .depression, anxiety, self-harming, any, any of those
kind of things that can be triggered by extreme circumstances.
(Male, parent/guardian, interview #16)
Taking ‘carer impact’ into consideration when making funding or policy decisions about
childhood vaccinations was considered essential, especially since this burden could have both
financial and psychological effects throughout the wider family unit. Nevertheless, participants
generally thought that the short-term care associated with looking after an ill child could
largely be coped with by family units, whilst the burden of long-term care had emotional and
financial impacts that should be avoided if at all possible.
I think you know as a, whatever, family unit you’ve got um, getting through that short-term
care burden is a lot easier than that long-term care burden, everything, emotionally, care
itself, financially. Um, so yeah definitely I think, and again, that must be a consideration for
the government in terms of how much money, um it costs to support a child and a family
with long term care needs and verses the cost of the vaccination.
(Female, parent/guardian, interview #18)
Preference for vaccine associated health benefits to be given to ‘socially disadvantaged’
children. Some participants were in favour of using socio-economic status to help inform
funding decisions about publicly funded childhood vaccination programmes. These opinions
were often based on the belief that there was a social dichotomy in the UK, whereby families
(or more specifically children) could be classified into either a socially advantaged or socially
disadvantaged group, with children in the socially disadvantaged group having lower underly-
ing health status and therefore their preference would be to target any health benefits to these
individuals.
I think probably they [socially disadvantaged children] haven’t got the food going into
them that the well-off people have, so I think they need it [vaccinations] more, they
wouldn’t be able to cope with the illness, I don’t think they would survive so easily.
(Female, not a parent/guardian, interview #13)
Overall, participants found it difficult to decide how health benefits might be fairly distrib-
uted in society and struggled with the ethical dimensions associated with this issue. When dis-
cussed further it became clear that some participant’s attitudes about social advantage/
disadvantage and rationing health benefits were often intertwined with perceptions of wealth;
whereby those children in the socially disadvantaged group would have fewer opportunities
for improving their underlying health.
Prioritising vaccination programmes against childhood diseases
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I wouldn’t be able to differentiate between either [socially advantaged or disadvantaged
children] because a human being is a human being. Err I, I don’t—I wouldn’t be able to dif-
ferentiate between them. If, if I had to I would say, erm possibly the poorer people in that
they don’t have the ability to possibly change their lifestyle. So presuming that lifestyle had
something to do with the illness, a rich person might be able to help themselves. That’s my
only reasoning there.
(Female, parent/guardian, interview #7)
Conversely, a few participants strongly believed that health benefits should be offered to all
children in the UK, irrespective of their socio-economic status.
I still think it should be absolutely across the board, whoever you are, if you’re aged two and
you get a vaccine, it doesn’t matter what socioeconomic status or where you live in the
country or if you’re in a high rise flat or your mum shops at Iceland or whatever it is, you as
that child should be included in that vaccination programme come hell or high water.
(Female, not a parent/guardian, interview #21)
Preferences associated with vaccine preventable diseases
Preferences for disease severity to be considered when vaccinating. A range of disease
severity was identified, with the general consensus in favour of prioritising vaccinations against
severe diseases that might cause long-term health implications, whilst milder self-limiting dis-
eases were thought to be less important to vaccinate against.
If it’s something that you can get over, without any long-term consequences, then I’m not
sure there’s a real need to be vaccinated against it. But if it could result in death or long-
term health consequences then I think it’s a different case.
(Female, parent/guardian and foster carer, interview #6)
Well, if it’s going to kill you without a shadow of a doubt there should be a vaccine for it. If
it’s going to disable you there should be a vaccine for it. If it’s gonna give you a sneeze, you
could consider whether or not to vaccine against it. So it depends on the effect on mortality
and the effect on potential creation of life-limiting conditions and potential disability.
(Female, not a parent/guardian, interview #21)
Focusing discussions around the impact of vaccine preventable diseases on children meant
that participants freely discussed the issue of long-term consequences as a key concern.
Because, you know, if, if you get a cold, or a fever, or whatever, you can just fight back from
that. But the long-term health implications, you know, could affect their futures, could
affect how they get jobs in the future, could affect their life and then you’ve got the affects
[on] their families.
(Female, not a parent/guardian, interview #13)
Preferences for disease incidence to be considered when vaccinating. Discussions
around the severity of disease often led to participants also considering the significance of
Prioritising vaccination programmes against childhood diseases
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disease incidence, as these two sub-themes were frequently interlinked. As with severity, varia-
tions in disease incidence were discussed by participants, ranging from rare to common. Par-
ticipants expressed a preference for prioritising childhood vaccinations against common
diseases, as this would represent better value for money.
[I]f it was only going affecting a few people, then. . .and it was, it was only mild and it was
only a week, then you know, your money might be better off spent on something which is a
bit—affects more people and has wider consequences.
(Female, parent/guardian, interview #18)
Health benefits associated with ‘declining infections’ offset against other attributes.
Participants were asked to think about whether childhood vaccinations should continue to be
funded for diseases that were declining. However, there were numerous comments concerning
the complexity of this issue, as it was felt that the reason for the decline needed to be identified
before a definitive decision could be made.
If it’s declining as a result of the vaccination policy then that’s absolutely not the point at
which to stop the vaccination policy. . .if it’s declined because it was the result of eating, I
don’t know, clam shells, and nobody eats clam shells anymore, then fine.
(Female, parent/guardian, interview #17)
Despite the complexity of the topic, most participants commented that declining diseases
should continue to be vaccinated because of the need to ensure that the disease does not re-
emerge in the future.
I think it’s really important that we continue funding vaccinations because, until you’ve
proved that the disease doesn’t exist in the world anymore, you’re effectively stopping fund-
ing the reasons for your success.
(Male, parent/guardian, interview #16)
Perception of risks and benefits associated with childhood vaccinations
Vaccine associated ‘side-effects’ offset by other attributes. The potential side-effects
associated with childhood vaccinations were a key issue for some participants, as there were
some concerns that the consequences of having a vaccination could potentially be worse than
contracting a disease.
Oh yes, side-effects are very important. Sometimes they’re worse than the disease and they
would have to be considered.
(Female, parent/guardian, interview #12)
However, numerous participants often discussed this concern in the context of the disease
that could be prevented and considered the potential for vaccine associated side-effects against
other attributes. These individuals believed that disease severity and incidence played a bigger
role in the funding decisions related to any national childhood vaccination programme.
Prioritising vaccination programmes against childhood diseases
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[I]t’s very subjective, so it would depend on the consequences of the diseases that you’re
being vaccinated against, weighed up against the side effects and the percentage chance of
being infected by the disease and the percentage risk of suffering from the side effects. So it
would be sort of fairly complex decision tree based on those factors, I think.
(Male, parent/guardian, interview #16)
Conflicting opinions about the risks and benefits of vaccine associated ‘herd protec-
tion’. The concept of herd protection was explained to all participants during the interview
process and the ensuing discussions showed that most individuals considered this an impor-
tant attribute in relation to prioritising funding for childhood vaccination programmes.
I would say I would favour the herd vaccination. . .because, erm, potentially much greater
benefits. Similar level of benefit for the individual, but a much greater level of benefit for
the collective.
(Male, parent/guardian, interview #16)
Yet some participants were concerned about the risks associated with vaccinations and felt
that the health and safety of their own children was more important than seeking a vaccination
that might confer herd protection and contribution to the health of the population.
[I]f everybody else has been vaccinated so that the disease isn’t prevalent, mine aren’t gonna
get it and I don’t have any risk of any of the possible complications, whether or not they
exist. So my core prejudice has always been to avoid any form of medication or interference,
but I’ve actually followed social rule and just gone and had it [vaccinations] done
(Female, parent/guardian, interview #17)
The social acceptability of childhood vaccinations that conferred herd protection was an
issue for several participants. This belief was aired from an individual perspective, but may
also reflect a more collectively shared opinion regarding the benefits of vaccine associated herd
protection.
Well I do think that the whole way in which immunisation programmes work to protect
whole societies is a really crucial aspect of their benefits, so being able to think beyond your
own individual wellbeing is fundamental to living in a good society.
(Female, parent/guardian, interview #4)
Conflicting opinions about the benefits of vaccine associated ‘peace of mind’. Some of
our participants suggested that the reassurance, or ‘peace of mind’, associated with childhood
vaccinations was a potential benefit worthy of consideration. These findings showed that
reducing anxiety might have a role to play in increasing an individual’s intention to vaccinate
and perhaps such preferences might need to be considered by policy makers when funding
childhood vaccination programmes in the future.
I think a lot of people do worry a lot and I think it can make their lives miserable. . .I think
some people do get a certain sense of ‘done that [vaccination], so I should be all right now’.
Prioritising vaccination programmes against childhood diseases
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If that makes them go out into the world feeling better. . .so peace of mind is always a good
investment.
(Female, parent/guardian, interview #17)
The peace of mind concept was also associated with a feeling of parental responsibility,
whereby failure to fully vaccinate children could be considered socially unacceptable or
irresponsible.
Yeah, I think peace of mind as a parent is, is very important. Knowing that your child has
got a tick in all the, all the vaccine boxes that it should have. I think that’s, yeah, that’s some-
thing that every parent should be looking out for and until you, until you’ve actually made
those arrangements and had those vaccinations given, you’ve fallen short in your parental
obligations.
(Male, parent/guardian, interview #16)
Conversely, a couple of participants believed that peace of mind should not be taken into
consideration when making decisions about childhood vaccinations. These individuals appre-
ciated that emotions might motivate some individuals in society to seek childhood vaccination;
nevertheless, it was considered unfitting for policy makers to make funding decisions from a
vaccine associated peace of mind perspective.
Well no, because there can be totally irrational fears like the whole MMR irrational thing,
um where no, no, no, no terrible to have an immunisation policy based on people’s emo-
tional feelings towards it.
(Female, parent/guardian, interview #4)
I don’t think that should come into it. I think that’s just for erm, individual’s peace of mind
and you can’t, you can’t vaccinate for that reason. You can only vaccinate to, to stop the
spread of diseases. You can’t put that in the equation, I don’t think.
(Female, parent/guardian, interview #11)
Discussion
Principal findings
We found that members of the public have preferences regarding the types of features that
should be taken into consideration when making funding decisions about childhood vaccina-
tions in the UK. Three main themes including nine key attributes influenced interview partici-
pants’ opinions. These were: (1) preferences associated with population segments, which were
linked to age group, carer impact and social group, (2) preferences associated with vaccine pre-
ventable diseases, which were attributed to disease severity, disease incidence and declining
infection, and (3) perception of risks and benefits associated with childhood vaccinations,
which were linked to vaccine associated side-effects, herd protection and peace of mind. Over-
all, participants demonstrated support for using criteria that both fall within and outside the
cost per QALY calculations. These findings indicate that the current economic analysis
approach, which assume that all QALYs are equal, may need to be refined when considering
childhood vaccinations.
Prioritising vaccination programmes against childhood diseases
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Strengths and weaknesses of the study
To our knowledge this is the first study to explore societal preferences for childhood vaccina-
tion priority setting in the UK. The qualitative interview data were obtained from members of
the public from two counties with differing vaccination uptake rates, which improves the gen-
eralisability of our study population. A weakness of this study was the sampling methods used;
504 individuals were invited to take part in the study using information recorded on the open
electoral registers for Bristol and South Gloucestershire, but only 21 individuals eventually par-
ticipated in the study. The open register is an extract of the electoral register and as such is an
incomplete list of electors and, moreover, does not list adults who are not eligible to vote.
Therefore, it is possible that our results do not truly represent the diversity of opinion within
the UK. Nevertheless, the broad range of preferences identified during the face-to-face inter-
views and the fact that data saturation was achieved would indicate that the qualitative results
presented provide an in-depth insight into the preferences of those participating. Analysis of
our qualitative data indicated that we recruited individuals with a range of opinions on vacci-
nations; individuals that were well informed about vaccines, individuals who were largely
unfamiliar with the topic and individuals with a range of opinions about vaccinations (anti-,
pro- and neutral-vaccine opinions). Nevertheless, purposefully recruiting a more diverse range
of qualitative interview participants may have provided a wider insight into current public
opinion and inclusion of some participants from non-white British ethnic backgrounds would
have been preferable.
Comparisons with existing literature
Our findings, that members of the public in the UK have preferences for attributes related to
who should be vaccinated and under what circumstances, are supported by other studies in
this area. Age (especially the youngest in society) was thought to be associated with disease vul-
nerability and thus felt to be a key priority group for vaccinations. A systematic review by Gu
et al (2015) also found that the youngest in society were often favoured when contemplating
health care priorities[26]. Age is implicitly included in the current QALY calculation as those
vaccinated at younger ages have more years of benefit ahead of them; further work is required
to estimate whether additional age-weighting is required.
Participants also discussed the ‘carer impact’ of diseases, which they believed should be con-
sidered when making childhood vaccination funding decisions. NICE methodology already
recommends that ‘[a]ll direct health effects, whether for patients or, when relevant, carers’
should be included in assessments[27] and whilst carer QALYs have been included in some
cost-effectiveness analyses, this approach is not done routinely and when implemented does
not form the base case. The rationale for excluding carer QALYs is often multifaceted, but pri-
marily results from a lack of data in some fields and the desire to ensure a consistent approach
with previous work. Therefore, unanswered questions remain about whether additional
weighting is required when considering the severity of the ‘carer impact’, in the same way
additional weighting may be required for disease compared to mild illness in persons directly
affected.
Some participants had clear notions of preferences associated with particular population
segments when prioritising childhood vaccinations based on social group, with socially disad-
vantaged children given precedence over socially advantaged children. This is in line with pre-
vious research studies considering public attitudes towards health inequalities and healthcare
priority setting, which found that members of the public tended to favour individuals with low
socioeconomic status (SES) compared to those with a high SES score for health care interven-
tions[28–33]. Our findings also showed that participants had preferences associated with
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disease related attributes, such as severity, incidence, and infection trends over time. These
findings add to the findings of Nord et al (2014 and 2015), who identified disease severity as
one of the most important attributes for consideration when setting health care priorities
[34,35].
The perception of risk and benefits associated with childhood vaccinations also influenced
our participants’ opinions. Discussions centred on vaccine associated side-effects, herd protec-
tion and peace of mind, although these preferences were often considered alongside other fac-
tors (e.g. such as disease severity) as part of the decision-making process. Side-effects were a
common concern raised during the interviews, whereby participants were less likely to priori-
tise vaccinations that might cause harm to children. A similar finding was reported by Sadique
et al (2013), whereby the severity of vaccine associated side-effects influenced mothers’ deci-
sion making processes about vaccinating their children, although the probability of these side-
effects occurring was not a consideration[36]. Side-effects were also considered by our study
participants in conjunction with herd protection, as those who believed vaccinations were
unsafe were less likely to accept the risk of vaccination in order to potentially protect others
from infection. This hesitation was akin to the public opinions reported by other previous UK
qualitative studies, which focused on parental decisions about MMR vaccinations[37, 38]. This
idea of parental decisions and ‘anticipated regrets’ associated with vaccinations was also dis-
cussed by Sadique et al (2013), an idea that seems closely akin to the ‘peace of mind’ attribute
identified during our qualitative study[36]. These anticipated regrets were described as a
trade-off between the risks associated with vaccine associated side-effects in instances when a
vaccination was taken, balanced against the potential for catching a vaccine preventable disease
in instances when a vaccination was not taken. This trade-off approach was similar to that
taken by participants in our study, who often made decisions by offsetting the benefits associ-
ated with ‘peace of mind’ against other preferences, such as disease severity[26, 36, 39, 40].
Meaning of the study: Possible explanations and implications for clinicians
and policy makers
Our findings show that the general public consider a range of population segment, disease and
vaccine specific attributes when evaluating the relative importance of different childhood vac-
cination programmes. These preferences include many attributes that would enter into a cost-
per QALY calculation, but may also go beyond the current aspects considered in the standard-
ised approach recommended by NICE for technology assessment economic evaluations. For
example, a preference for vaccinating younger rather than older individuals, which is greater
than currently accounted for by the standardised approach. Thus it would seem that the public
may not consider QALYs gained to be equal across and between people for a number of attri-
butes. Policymakers considering introducing new vaccine programmes, or modifying existing
ones, should consider whether, and how best, to include such societal preferences into their
decision making.
Unanswered questions and future research
Our findings suggest that some members of the UK general public have more nuanced views
than those allowed by the health-maximisation approach when considering how childhood
vaccines should be prioritised. Our participants identified several attributes that they believed
policy makers should consider when making childhood vaccination priority decisions, how-
ever ascribing relative weights to any of the qualitative preferences is not possible; although
this may be a fruitful area of future work. Indeed, the attributes identified during this qualita-
tive study will be used to develop a discrete choice experiment, which will be used to capture
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UK population preference weights to help inform the future prioritisation of childhood vacci-
nation programmes. This approach will identify the ‘weighting’[41] that members of the wider
UK public ascribe to the attributes identified as part of this study. This proposed research will
help determine whether to, and how, policy makers should include such preferences in deci-
sion making. Such findings will be used to inform discussions around the development and
implementation of improved cost-effectiveness approaches for evaluating childhood vaccina-
tion programmes.
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